Dhanuka Agritech Announces Investor Presentation for Q2 & Half Year Ended Sep 30, 2025
Dhanuka Agritech releases investor presentation for Q2 & Half Year ended September 30, 2025, reporting a decrease in revenue, EBITDA and PAT compared to Q2 FY24. The company expects flat revenue growth.
The financial results indicate a decline in revenue and profit, which could have a moderate impact on investor sentiment. The launch of new products has a positive impact.
The announcement primarily discusses the release of the investor presentation and financial results, which include both positive and negative aspects (e.g., new product registration vs. decreased profits).
* Dhanuka Agritech has released its investor presentation on the unaudited financial results for the quarter and half year ended 30th September 2025. * The company reported revenue from operations at ₹598.25 crore in Q2 FY26, compared to ₹654.28 crore in Q2 FY25. * EBITDA stood at ₹136.73 crore in Q2 FY26, versus ₹159.58 crore in the corresponding quarter of the previous year. * Profit after tax (PAT) was ₹93.97 crore in Q2 FY26, down from ₹117.52 crore in Q2 FY25. * The company expects flat revenue growth and an approximate 100bps decline in EBITDA for FY26. * Dhanuka received the Registration Certificate of Ipflufenoquin for indigenous manufacture u/s 9(3) for use in Transplanted Paddy for the control of Leaf blast & Neck blast in collaboration with Nisso Chemicals, Japan. * Trial production of the second product from Dahej Plant has started and sales of Bifenthrin from Dahej are on track. * Mr. Mahendra Kumar Dhanuka mentioned that abnormal and uneven rainfall distribution led to significant crop losses in various states, impacting agrochemical demand.
What to do with a filing like this
Dhanuka Agritech Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dhanuka Agritech Limited. Read the original for the full detail.